Interferon treatment in polycythaemia vera

Leukemia and Lymphoma

Volumn 22, Issue SUPPL. 1, 1996, Pages 143-148

  Reilly, J T ^a   Vellenga, E ^b   De Wolff, J Th M ^b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b Division of Haematology   (Netherlands)

Author keywords

Polycythaemia vera; Pruritus; interferon

Indexed keywords

ALPHA INTERFERON; IMMUNOMODULATING AGENT; IRON; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

BONE MARROW SUPPRESSION; CHRONIC MYELOID LEUKEMIA; HEMATOCRIT; HUMAN; IMMUNOTHERAPY; INFLUENZA; IRON DEFICIENCY; IRON METABOLISM; LEUKEMIA; LEUKOPENIA; MYELOFIBROSIS; NEUROTOXICITY; PHLEBOTOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PRURITUS; REVIEW; SIDE EFFECT; SPLENOMEGALY; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0029859019     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609074372     Document Type: Review

References (64)

1. Berlin, N. I. (1975) Diagnosis and classification of the polycythemias. Seminars in Hematology, 12, 339-351.
2. Adamson, J. W., Fialkow, P. J., Murphy, S., Prchal, J. F. and Steinmann, L. (1976) Polycythemia vera: stem cell and probable clonal origin of the disease. New England Journal of Medicine, 295, 913-919.
3. Wolf de, J. Th. M., Beentjes, J. A. M., Esselink, M. T., Smit, J. W., Halle, M. R., Clark, S. C. and Vellenga, E. (1989) In polycythemia vera human IL-3 and GM-CSF enhance erythroid colony forming growth in the absence of erythroietin. Experimental Hematology, 17, 981-983.
4. Wolf de, J. Th. M., Hendriks, D. W., Esselink, M. T., Halie, M. R. and Vellenga, E. (1994) The effects of IL-1 and IL-4 on the Epo independent erythroid progenitor in polycythemia vera. British Journal of Haematology, 80, 242-246.
5. Muller, E. W., Wolf de, J. Th. M., Hendriks, D. W., Esselink, M. T., Halie, M. R. and Vellenga, E. (1995) Recombinant human mast cell growth factor supports erythroid colony formation in polycythemia vera in the presence and absence of erythropoietin and serum. Experimental Haematology, 21, 1353-1357.
6. Correa, P. N., Eskinazi, D. and Axelrad, A. A. (1994) Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-I in vitro: studies in an improved serumfree medium. Blood, 83, 99-112.
7. Dai, C. H., Krantz, S. B., Dessypris, E. N., Means, R. T., Horn, S. T. and Gilbert, H. S. (1992) Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony stimulating factor. Blood, 80, 891-899.
8. Berk, P. D., Golsberg, G. D., Donovan, P. B., Fruchtman, S. M., Berlin, N. J. and Wasserman, L. R. (1986) Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Seminars in Haematology, 23, 132-143.
9. Landaw, S. A. (1986) Acute leukemia in polycythemia vera. Seminars in Haematology, 23, 156-165.
10. Kaplan, M. E., Mack, K. and Goldberg, J. D. et al. (1986) Long-term management of polycythemia vera with hydroxyurea. Seminars in Haematology, 23, 167-171.
11. Löfvenberg, E. and Wahlin, A. (1988) Management of polycythemia vera, essential thrombocythemia and myelofibrosis with hydroxyurea. European Journal of Haematology, 41, 375-381.
12. Weinfeld, A., Swolin, B. and Westin, J. (1994) Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: Prospective study of efficacy and leukaemogenicity with therapeutic implications. European Journal of Haematology, 52, 134-139.
13. Nand, S., Messmore, H., Fisher, S. G., Bird, M. L., Schultz, W. and Fischer, R. I. (1990) Leukemic transformation in polycythemia vera: analysis of risk factors. American Journal of Haematology, 34, 32-36.
14. Salem, H. H., Van der Weyden, M. B., Young, I. F. and Wiley, J. S. (1982) Pruritus and severe iron deficiency in polycythaemia. British Medical Journal, 285, 91-92.
15. Talpaz, M., Kantarjian, H. M., McCredie, K., Trujillo, J. M., Keating, M. J. and Gutterman, J. U. (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. New England Journal of Medicine, 314, 1065-1069.
16. Talpaz, M., Mavligit, G., Keating, M, Walters, R. S. and Gutterman, J. U. (1983) Human leukocyte interferon to control thrombocytosis in chronic myeloid leukaemia. Annals of Internal Medicine, 99, 789-792.
17. Ludwig, H., Linkesch, W., Gisslinger, H., Fritz, E., Sinzinger, H., Radaszkiewicz, T., Chott, A., Roswitha, F. and Micksche, M. (1987) Interferon alfa corrects thrombocytosis in patients with myeloproliferative disorders. Cancer Immunology Immunotherapy, 25, 266-273.
18. Giles, F. J., Gray, A. G., Brozovic, M., Grant, I. D., Machin, S. J., Richards, J. D. M., Venutas, S., Singer, C. R., Yong, K. L., Davies, S. C., Hoffbrand, A. U., Mehta, A. B., Thomas, M. J. G. and Goldstone, A. H, (1988) Alpha-interferon therapy for essential thrombocythaemia. Lancet, 2, 70-72.
19. Barosi. G., Libertato, L. N., Costa, A and Ascari, E. (1989) Cytoreductive effects of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia. Blut, 58, 271-274.
20. Silver, R. T. (1993) Interferon-α2b: a new treatment for polycythemia vera. Annals of Internal Medicine, 119, 1091-1092.
21. Cacciola, E., Giustolisi, R., Guglielmo, P., Di Raimondo, F., Cacciola, E. and Calogero, R. D. (1991) Recombinant interferon α in the treatment of polycythemia vera. Blood, 77, 2790.
22. Turn, D., Mitra, M. E., Di Trapani, R., Lipani, M. G., Perricone, R. and Cajozzo, A. (1991) Interferon in polycythemia vera and essential thrombocythemia. Haematologica, 76, 75-77.
23. Wolf de, J. Th. M., Hendriks, D. W., Egger, R. C., Esselink, M. T., Halie, M. R. and Vellenga, E. (1991) α-interferon for intractable pruritus in polycythemia vera. Lancet, i, 241.
24. Messora, C., Bensi, L., Vecchi, A., Longo, R., Giacobbi, F., Temperani, P., Bevini, M., Emilia, G. and Sacchi, S. (1994) Cytogenetic conversion in a case of polycythaemia vera treated with interferon-alpha. British Journal of Haematology, 86, 402-404.
25. Papineschi, F., Bucalossi, A., Capochiani, E., Benedetti, E., Bramanti, E., Dastoli, G., Dispensa, E., Benedetti, E. and Spremolla, G. (1994) Recombinant α2a interferon and polycythemia vera: Clinical results and biological evaluation by means of Fourier-transform infrared microspectroscopy. European Journal of Haematology, 53, 213-217 .
26. Muller, E. W., de Wolf, J. Th. M., Egger, R., Wijermans, P. W., Huijgens, P. C., Halie, M. R. and Vellenga, E. (1995) Long-term treatment with interferon-α2b for severe pruritus in patients with polycythaemia vera. British Journal of Haematology, 89, 313-318.
27. Taylor, P. C., Dolan, G., Ng, J-P., Paul, B., Collin, R. and Reilly, J. T. (1995) Efficacy of recombinant interferon alpha (rIFNα) in polycythaemia vera: a study of 17 patients and an analysis of published data. British Journal of Haematology, (in press).
28. Giles, F. J., Gray, A. G., Carmichael, D. S., Williams, Y. F., Brosovic, M. and Goldstone, A. H. (1991) Resistant polycythaemia vera successful therapy with non recombinant or recombinant alpha interferon. British Journal of Haematology, 77, (suppl 1), 663.
29. Brand, C. M., Leadbeater, L., Budiman, R., Lechner, K. and Gisslinger, H. (1994) Successful re-treatment of an anti-interferon resistant polycythaemia vera patient with lymphoblastoid interferon-αN1 and in vitro studies on the specificity of the antibodies. British Journal of Haematology, 86, 216-218.
30. Castello, G., Lerza, R., Cerruti, A., Cavallini, D., Bogliolo, G. and Pannacciulli, I. (1994) The in vitro and in vivo effect of recombinant interferon α-2a on circulating haemopoietic progenitors in polycythaemia vera. British Journal of Haematology, 87, 621-623.
31. Teofili, L., De Stefano, V., lovino, M. S., Voso, M. T., Tartaglione, R., Bizzi, B. and Leone, G. (1992) Disappearance of spontaneous erythroid colonies in patients with myeloproliferative disorders treated by alpha interferon. British Journal of Haematology, 81, 310-311.
32. Finelli, C., Gugliotta, L., Gamberi, B., Vianelli, N., Visani, G. and Tura, S. (1993) Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa. American Journal of Haematology, 43, 316-318.
33. Kantarjian, H. M., Deisseroth, A., Kurzrock, R., Estrov, Z. and Talpaz, M. (1993) Chronic myelogenous leukaemia: a concise update. Blood, 82, 691-703.
34. Tura, S., Baccarani, M., Zuffa, E., Russo, D., Fanin, R., Zaccaria, A., Fiacchini, M. and the Italian Cooperative Study Group on chronic myeloid leukaemia (1994) Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukaemia, New England Journal of Medicine, 330, 820-825.
35. Yoffe, G., Blick, M., Kantarjian, H. M., Spitzer, G., Gutterman, J. and Talpaz, M. (1987) Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukaemia. Blood, 69, 961-963.
36. Swolin, B., Weinfeld, A. and Westin, J. (1988) A prospective long-term cytogenetic study in polycythemia in relationship to treatment and clinical course. Blood, 72, 386-395.
37. Hino, M., Futami, E., Okuno, S., Miki, T., Nishizawa, Y. and Morii, H. (1993) Possible selective effects of interferon α-2b on a malignant clone in a case of polycythemia vera. Annals of Haematology, 66, 161-162.
38. Gale, R. E. and Wainscoat, J. S. (1993) Clonal analysis using X-linked DNA polymorphisms. British Journal of Haematology, 85, 2-8.
39. Wasserman, L. R. (1976) The treatment of polycythemia vera. Seminars in Haematology, 13, 57-78.
40. Fjellner, B. and Hägermark, O. (1979) Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement. Acta Dermatology and Venereology, 59, 505-512.
41. Steinman, H. K., Kobza-Black, A., Lotti, T. M., Brunetti, L., Panconesti, E. and Greaves, M. W. (1987) Polycythaemia vera and water induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge. British Journal of Dermatology, 116, 329-333.
42. Gilbert, H. S., Warner, R. R. P. and Wasserman, L. R..(1966) A study of histamine in myeloproliferative disease. Blood, 28, 795-806.
43. Swerlick, R. A. (1995) Photochemotherapy treatment of pruritus associated with polycythemia vera. Journal of the American Academy of Dermatology, 13, 675-677.
44. Denman, S. T. (1986) A review of pruritus. Journal of American Academy of Dermatology, 14, 375-392.
45. Jackson, N., Burt, D., Crocker, J. and Boughton, B. (1987) Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus. British Journal of Dermatology, 116, 21-29.
46. Chanarin, I. and Szur, L. (1975) Relief of intractable pruritus in polycythemia rubra vera with cholestyramine. British Journal of Haematology, 29, 669-670.
47. Weick J. K., Donovan, P. B., Najean, Y., Dresch, C., Pisciotta, A. V., Cooperberg, A. A., and Goldberg, J. D. (1982). The use of cimetidine for the treatment of pruritus in polycythemia vera. Archives of Internal Medicine, 142, 241-242.
48. Huffman, R. and Boswell, H. S. (1995) Polycythemia vera. In 'Hematology: Basic Principles and Practice'. Edited by R. Hoffman, E. J. Benz, S. J. Shattil, B. Furie, H. J. Cohen and L. E. Silberstein, pp. 1121-1142. New York: Churchill Livingstone.
49. Ariad, S. and Bezwoda, W. R. (1991) α-interferon for polycythemia vera. Blood, 77, 670.
50. Dallman, P. R., Beutler, E., Finch, C. A. (1978) Effects of iron deficiency exclusive of anaemia. British Journal of Haematology, 40, 179-184.
51. Rector, W. G., Fortuin, N. J. and Conley, C. L. (1982) Nonhematologic effects of chronic iron deficiency: a study of patients with polycythemia vera treated solely with venesections. Medicine (Baltimore), 61, 382-389.
52. Silverstein, M. N. (1976) The evolution into and the treatment of late stage polycythemia vera. Seminars in Haematology, 13, 79-84.
53. Ascari, E., Baresi, G., Carlo-Stella, C., Cazzola, M., Dazza, L., Ganser, A., Meloni, F., Melzer, D. and Pedrazzoli, P. (1987) Effects of recombinant and gamma interferons on the in vitro growth of circulating hematopoietic stem cells (CFU-GEMM, CFU-MK, BFU-C and CFU-GM) from patients with myelofibrosis and with myeloid metaplasia. Blood, 70, 1014-1019.
54. Carlo-Stella, C., Ganser, A., Greher, J., Hoelzer, D. and Vokers, B. (1987) Effects of recombinant interferons alpha and gamma on human bone marrow derived megakaryocyte progenitor cells. Blood, 70, 1173-1179.
55. Lin, S. L., Kikuchi, T., Pledger, W. J., Tamm, I. (1986) Interferon inhibits the establishment of competence in G°/S phase transition. Science, 233, 356-359.
56. Reilly, J. T. (1994) Pathogenesis of idiopathic myelofibrosis: present status and future directions. British Journal of Hematology, 88, 1-8.
57. Gasti, G., Lang, A., Huber, C. and Seewann, H. (1988) Interferon alpha for idiopathic myelofibrosis. Lancet, i, 765-766.
58. Hasselbalch, H. (1988) Interferon in myelofibrosis. Lancet, i, 355.
59. Parmeggiani, L., Ferrant, A., Rodhain, J., Michaux, J. L. and Sokal, G. (1987) Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia. European Journal of Haematology, 39, 228-232.
60. Seewan, H. L., Gastl, G., Lang, A., Abbrederis, K., Thaler, J., Flener, R. and Huber, C. (1988) Interferon alpha 2 in the treatment of idiopathic myelofibrosis. Blut, 58, 15-19.
61. List, A. F. and Doll, D. C. (1992) Alpha-interferon in the treatment of idiopathic myelofibrosis. British Journal of Haematology, 80, 566-567.
62. Amarto, E. P., Byrne, M. H., Grantstein, R. D., Margolis, R. J. and Murphy, C. F. (1987) Gamma interferon inhibits collagen synthesis in vivo in the mouse. Journal of Clinical Investigation, 79, 1254.
63. Martyré, M-C., Magdelenat, H. and Calvo, F. (1991) Interferon-γ in vivo reverses the increased platelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia. British Journal of Haematology, 77, 431-435.
64. Clemens, M. (1986) Interferons and oncogenes. Nature, 313, 531-532.